ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,466,790, issued on Nov. 11, was assigned to IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY (Riyadh, Saudi Arabia).
"Bis urea-based organoselenium compound and method for treating cancer" was invented by Tarek Ahmed Yousef (Riyadh, Saudi Arabia), Saad Shaaban (Almansourah, Egypt), Ahmed A. Al-Karmalawy (Baghdad), Marwa Sharaky (Cairo), Hussein Ba-Ghazal (Riyadh, Saudi Arabia) and Mohamed Alaasar (Halle Saale, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "A method of treating cancer including administering a bis-(organoselanyl urea)aryl agent having a Formula (I) to a subject with cancer. The method includes effective inhibition of growth of cancer ce...